Fenwick & West Represents Augmedix in $7.3M Financing

June 20, 2014

Fenwick & West LLP represented Augmedix, Inc., a service powered by Google Glass that reclaims the hours physicians spend on the computer entering or retrieving data from electronic health records and refocuses them on what matters most: patient care, in its recently announced $7.3 million round of venture financing. The round was led by DCM and Emergence Capital Partners. As part of the financing, Peter Moran of DCM and Kevin Spain of Emergence will join the Augmedix board of directors.

The new funds will help to fuel expansion within pilot partner, Dignity Health, as well as other provider groups throughout the nation. More information about Augmedix’s $7.3M financing can be obtained from the company press release.

The Fenwick transaction team was led by corporate partner Michael Esquivel and corporate associates Derek Huoth and Nam Kim. ​